||EPS - Basic
||Market Cap (m)
Healthcare Inv Share Discussion Threads
Showing 26 to 49 of 50 messages
|HIO now moved to COS|
|Sorry I can't Mirabeau as I'm not a subscriber! I've set up a new thread on M----am. :-)|
|Set one up ffs!|
|No new thread as yet, latifs. The new epic is COS.|
|this is now called collagen solutions. is here a new thread?|
|From an article in the Daily Mail published 31st July. Flotation was in April.
"At the time of HIO's flotation Evans was granted options over 4.05million shares (10 per cent of the equity), which will only vest in the event that an acquisition is completed within 12 months from admission, and if the share price is in excess of 20p per share.
Once vested, the exercise period of the options will be 10 years and the exercise price will be 10p per share. Evans has a big City fan club and it is easy to see why. The companies under his stewardship have a strong record of value generation for shareholders.
He was chief executive of Shield Diagnostics prior to the merger with Axis Biochemicals to form Axis Shield in 1999. He was also chairman of Immunodiagnostic Systems, which floated in December 2004 at 51p and was trading at 1046p at the time he left the company in September 2011."|
RNS Number : 4668W
Healthcare Investment Opportunities
27 December 2013
27 December 2013
Healthcare Investment Opportunities Plc
Healthcare Investment Opportunities plc (AIM: HIO), an investment company focusing on the healthcare sector, announces that today Malcolm Gillies, a Director of Healthcare Investment Opportunities, has purchased a total of 250,000 ordinary shares at an average price of 12.789 pence per share.
This brings Malcolm Gillies' interest in the Company's current issued share capital to 500,000 being 1.24% of the current issued share capital.|
|David Evans has a pretty impressive track record. Nice little delayed trade just gone through.|
|rivaldo, tend to agree with you. Will carry on watching from the sidelines.|
|Been following this one for a while without buying, but I must say I find today's acquisition most uninspiring/disappointing.
Quite happy to be put right, but it seems the market agrees with me so far.|
|It is well past the six months timescale predicted in the prospectus ,perhaps we will hear soon some news|
|Something stirring here at last?|
|I am a little frustrated no news and well past 6 months. Still they say no news is good news|
|Nice tick up again this morning.|
|Further tick up this morning, and looking like is all buys|
|Large late buy at 15. Presumably these swings follow potential investments brewing and then fading. Something probably brewing|
|Admitted to AIM on 10th April so the clock is ticking now and not long left until the six months is up.
"The Board, through its extensive network of contacts, has identified a number of potentially interesting investment opportunities, although formal discussions in respect of any of these opportunities have not yet commenced. The Board anticipates the first acquisition will be a reverse takeover, in accordance with the AIM Rules for Companies, will be subject to prior shareholder approval and the publication of an admission Document and is expected to be made within 6 months of Admission. In addition, the Board may also consider making other smaller acquisitions or investments although the Directors do not intend to create a portfolio of unconnected companies."|
|Something's beginning to bubble here, I agree Master RSI.|
|Bouncing after retracement, some large buys for the last couple days and Market Makers looking like short of stock|
|Delayed trades put through this afternoon, I suppose some of the people who bought in at the original float price in April might be happy to cash in on their profit. I'm happy to wait this one out, even if it takes 7 years for David Evans to put in a similar performance to the one when he was chairman of Immundiagnostic Systems !|
|Buyers paying the full offer price of 17p now.|
|Evans is a respected figure in the City. His credentials are impeccable but this stock's speculative but if anyone's got the expertise and experience to succeed then Evans surely has|
|I like the last sentence of that article in the Daily Mail - referring to David Evans. He's certainly got a good CV !
"He was also chairman of Immunodiagnostic Systems, which floated in December 2004 at 51p and was trading at 1046p at the time he left the company in September 2011."|
|I've just bought a few tpinvest, whether or not the hot gossip turns out to be accurate it would appear that David Evans has a good track record - so this is worth a punt imo.|